“…Amidst several health benefits due to increasingly understood pharmacological profile (Liu et al, 2015), preclinical evidence proved XN's action as antithrombotic (Xin et al, 2017), hepatoprotective (Weiskirchen, Mahli, Weiskirchen, & Hellerbrand, 2015), and antiatherosclerotic (Hirata et al, 2017). While XN's anti-carcinogenic properties, both alone and combined with other phenolic constituents extracted from malts and hops, have been revealed in vitro since some time (Ferk et al, 2010;Gerhäuser, 2005;Karabin, Hudcova, Jelinek, & Dostalek, 2015;Żołnierczyk et al, 2015), positive results of the first human intervention trials showed early clinical evidence (Pichler et al, 2017).…”